Global Drug Abuse Treatment Industry Analysis 2019, Market Growth, Trends, Opportunities Forecast To 2024

Summary

WiseGuyReports.com adds “Drug Abuse Treatment Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
Factors such as frequent product launches, approval and robust pipeline of novel biopharmaceutical products, growing patient awareness, higher treatment seeking rate, growing government recognition and intervention of the issue, as well as encouragement to curb substance abuse in all countries are driving the growth of drug abuse treatment market globally.
In 2018, the global Drug Abuse Treatment market size was 14500 million US$ and it is expected to reach 22700 million US$ by the end of 2025, with a CAGR of 6.6% during 2019-2025.

This report focuses on the global Drug Abuse Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Abuse Treatment development in United States, Europe and China.

The key players covered in this study
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3857783-global-drug-abuse-treatment-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence

Market segment by Application, split into
Hospital & Clinics
Residential (non-hospital)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Drug Abuse Treatment status, future forecast, growth opportunity, key market and key players.
To present the Drug Abuse Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Drug Abuse Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

At Any Query @ https://www.wiseguyreports.com/enquiry/3857783-global-drug-abuse-treatment-market-size-status-and-forecast-2019-2025

Major Key Points in Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drug Abuse Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Opioid Addiction
1.4.3 Tobacco/Nicotine Addiction
1.4.4 Alcohol Dependence
1.5 Market by Application
1.5.1 Global Drug Abuse Treatment Market Share by Application (2014-2025)
1.5.2 Hospital & Clinics
1.5.3 Residential (non-hospital)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Drug Abuse Treatment Market Size
2.2 Drug Abuse Treatment Growth Trends by Regions
2.2.1 Drug Abuse Treatment Market Size by Regions (2014-2025)
2.2.2 Drug Abuse Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

…..

12 International Players Profiles
12.1 Indivior
12.1.1 Indivior Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drug Abuse Treatment Introduction
12.1.4 Indivior Revenue in Drug Abuse Treatment Business (2014-2019)
12.1.5 Indivior Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drug Abuse Treatment Introduction
12.2.4 Pfizer Revenue in Drug Abuse Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Alkermes
12.3.1 Alkermes Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drug Abuse Treatment Introduction
12.3.4 Alkermes Revenue in Drug Abuse Treatment Business (2014-2019)
12.3.5 Alkermes Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drug Abuse Treatment Introduction
12.4.4 Novartis Revenue in Drug Abuse Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Mylan
12.5.1 Mylan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drug Abuse Treatment Introduction
12.5.4 Mylan Revenue in Drug Abuse Treatment Business (2014-2019)
12.5.5 Mylan Recent Development
12.6 Cipla
12.6.1 Cipla Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drug Abuse Treatment Introduction
12.6.4 Cipla Revenue in Drug Abuse Treatment Business (2014-2019)
12.6.5 Cipla Recent Development
12.7 Glenmark
12.7.1 Glenmark Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drug Abuse Treatment Introduction
12.7.4 Glenmark Revenue in Drug Abuse Treatment Business (2014-2019)
12.7.5 Glenmark Recent Development
12.8 Dr. Reddy's Laboratories
12.8.1 Dr. Reddy's Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drug Abuse Treatment Introduction
12.8.4 Dr. Reddy's Laboratories Revenue in Drug Abuse Treatment Business (2014-2019)
12.8.5 Dr. Reddy's Laboratories Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drug Abuse Treatment Introduction
12.9.4 Teva Pharmaceutical Revenue in Drug Abuse Treatment Business (2014-2019)
12.9.5 Teva Pharmaceutical Recent Development
12.10 PLIVA (Odyssey)
12.10.1 PLIVA (Odyssey) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drug Abuse Treatment Introduction
12.10.4 PLIVA (Odyssey) Revenue in Drug Abuse Treatment Business (2014-2019)
12.10.5 PLIVA (Odyssey) Recent Development

Continued....

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)